These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25147205)

  • 21. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Liu X; Mayeda A; Tao M; Zheng ZM
    J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease.
    Claverie-Martin F; Gonzalez-Paredes FJ; Ramos-Trujillo E
    RNA Biol; 2015; 12(4):369-74. PubMed ID: 25757501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AG-dependent 3'-splice sites are predisposed to aberrant splicing due to a mutation at the first nucleotide of an exon.
    Fu Y; Masuda A; Ito M; Shinmi J; Ohno K
    Nucleic Acids Res; 2011 May; 39(10):4396-404. PubMed ID: 21288883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-splicing of mature mRNA in cancer cells promotes activation of distant weak alternative splice sites.
    Kameyama T; Suzuki H; Mayeda A
    Nucleic Acids Res; 2012 Sep; 40(16):7896-906. PubMed ID: 22675076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative evaluation of all hexamers as exonic splicing elements.
    Ke S; Shang S; Kalachikov SM; Morozova I; Yu L; Russo JJ; Ju J; Chasin LA
    Genome Res; 2011 Aug; 21(8):1360-74. PubMed ID: 21659425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells.
    Palhais B; Præstegaard VS; Sabaratnam R; Doktor TK; Lutz S; Burda P; Suormala T; Baumgartner M; Fowler B; Bruun GH; Andersen HS; Kožich V; Andresen BS
    Nucleic Acids Res; 2015 May; 43(9):4627-39. PubMed ID: 25878036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
    Amendt BA; Hesslein D; Chang LJ; Stoltzfus CM
    Mol Cell Biol; 1994 Jun; 14(6):3960-70. PubMed ID: 8196635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive selection acting on splicing motifs reflects compensatory evolution.
    Ke S; Zhang XH; Chasin LA
    Genome Res; 2008 Apr; 18(4):533-43. PubMed ID: 18204002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
    Damgaard CK; Tange TO; Kjems J
    RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HIV-1 major splice donor D1 is activated by splicing enhancer elements within the leader region and the p17-inhibitory sequence.
    Asang C; Erkelenz S; Schaal H
    Virology; 2012 Oct; 432(1):133-45. PubMed ID: 22749061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor.
    Zheng ZM; He P; Baker CC
    J Virol; 1996 Jul; 70(7):4691-9. PubMed ID: 8676495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-mRNA secondary structures influence exon recognition.
    Hiller M; Zhang Z; Backofen R; Stamm S
    PLoS Genet; 2007 Nov; 3(11):e204. PubMed ID: 18020710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo.
    Zheng ZM; Quintero J; Reid ES; Gocke C; Baker CC
    J Virol; 2000 Jul; 74(13):5902-10. PubMed ID: 10846071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5' splice sites.
    Sahashi K; Masuda A; Matsuura T; Shinmi J; Zhang Z; Takeshima Y; Matsuo M; Sobue G; Ohno K
    Nucleic Acids Res; 2007; 35(18):5995-6003. PubMed ID: 17726045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
    Jacquenet S; Méreau A; Bilodeau PS; Damier L; Stoltzfus CM; Branlant C
    J Biol Chem; 2001 Nov; 276(44):40464-75. PubMed ID: 11526107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why Selection Might Be Stronger When Populations Are Small: Intron Size and Density Predict within and between-Species Usage of Exonic Splice Associated cis-Motifs.
    Wu X; Hurst LD
    Mol Biol Evol; 2015 Jul; 32(7):1847-61. PubMed ID: 25771198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.
    Erkelenz S; Poschmann G; Theiss S; Stefanski A; Hillebrand F; Otte M; Stühler K; Schaal H
    J Virol; 2013 Mar; 87(5):2721-34. PubMed ID: 23255807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.